A detailed history of Ckw Financial Group transactions in Sanofi stock. As of the latest transaction made, Ckw Financial Group holds 4,450 shares of SNY stock, worth $237,407. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,450
Previous 4,450 -0.0%
Holding current value
$237,407
Previous $255,000 15.69%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$48.54 - $58.53 $24,270 - $29,265
-500 Reduced 10.1%
4,450 $255,000
Q4 2022

Jan 18, 2023

BUY
$38.86 - $48.55 $19,430 - $24,275
500 Added 11.24%
4,950 $240,000
Q2 2022

Aug 04, 2022

SELL
$48.99 - $57.46 $63,687 - $74,698
-1,300 Reduced 22.61%
4,450 $227,000
Q1 2022

Apr 28, 2022

BUY
$48.48 - $53.65 $63,023 - $69,745
1,300 Added 29.21%
5,750 $300,000
Q4 2021

Feb 09, 2022

SELL
$47.07 - $52.35 $9,414 - $10,470
-200 Reduced 4.3%
4,450 $220,000
Q3 2021

Nov 12, 2021

BUY
$47.89 - $53.12 $57,468 - $63,744
1,200 Added 34.78%
4,650 $223,000
Q1 2021

May 13, 2021

BUY
$45.46 - $50.51 $74,281 - $82,533
1,634 Added 89.98%
3,450 $171,000
Q4 2020

Feb 10, 2021

SELL
$45.3 - $51.62 $36,240 - $41,296
-800 Reduced 30.58%
1,816 $88,000
Q2 2020

Aug 12, 2020

SELL
$42.91 - $52.5 $4,291 - $5,250
-100 Reduced 3.68%
2,616 $134,000
Q1 2020

May 12, 2020

SELL
$38.02 - $51.66 $22,812 - $30,995
-600 Reduced 18.09%
2,716 $117,000
Q4 2019

Feb 07, 2020

SELL
$44.25 - $50.86 $4,425 - $5,086
-100 Reduced 2.93%
3,316 $166,000
Q2 2019

Aug 12, 2019

BUY
$40.43 - $44.3 $4,043 - $4,430
100 Added 3.02%
3,416 $148,000
Q4 2018

Jan 16, 2019

SELL
$41.48 - $45.59 $8,296 - $9,118
-200 Reduced 5.69%
3,316 $144,000
Q3 2017

Nov 13, 2017

BUY
$47.04 - $50.34 $165,392 - $176,995
3,516
3,516 $175,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $134B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Ckw Financial Group Portfolio

Follow Ckw Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ckw Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Ckw Financial Group with notifications on news.